These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

195 related articles for article (PubMed ID: 15906187)

  • 21. In memoriam: James J. Rahal Jr, MD.
    Segal-Maurer S; Urban C; Rubin DS; Wehbeh W
    Clin Infect Dis; 2011 Dec; 53(12):1301-2. PubMed ID: 22052895
    [No Abstract]   [Full Text] [Related]  

  • 22. Viral hepatitis at a crossroad.
    Lok AS; Pawlotsky JM
    Gastroenterology; 2012 May; 142(6):1261-3. PubMed ID: 22537431
    [No Abstract]   [Full Text] [Related]  

  • 23. Late hepatitis B virus relapse in patients co-infected with hepatitis B virus and hepatitis C virus after antiviral treatment with pegylated interferon-a2b and ribavirin.
    Potthoff A; Berg T; Wedemeyer H;
    Scand J Gastroenterol; 2009; 44(12):1487-90. PubMed ID: 19900055
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Direct-acting antivirals and hepatitis B virus (HBV) reactivation in co-infected HBV/HCV kidney-transplant recipients.
    Pol S; Marion O; Vallet-Pichard A; Meritet JF; Sauné K; Alric L; Kamar N
    Transpl Infect Dis; 2018 Jun; 20(3):e12864. PubMed ID: 29512231
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Hepatitis B Virus Infection and Hepatitis C Virus Treatment in a Large Cohort of Hepatitis C-Infected Patients in the United States.
    Moorman AC; Xing J; Rupp LB; Gordon SC; Spradling PR; Boscarino JA; Schmidt MA; Daida YG; Teshale EH; Holmberg SD;
    Gastroenterology; 2018 Feb; 154(3):754-758. PubMed ID: 29360428
    [No Abstract]   [Full Text] [Related]  

  • 26. Hepatitis B and C viruses: molecular identification and targeted antiviral therapies.
    Berenguer M; Wright TL
    Proc Assoc Am Physicians; 1998; 110(2):98-112. PubMed ID: 9542765
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Infectious disease. West Nile drugs, vaccine still years away.
    Enserink M
    Science; 2000 Nov; 290(5496):1483. PubMed ID: 11185501
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Application of structural biology tools in the study of viral hepatitis and the design of antiviral therapy.
    Yao N; Hong Z; Lau JY
    Gastroenterology; 2002 Oct; 123(4):1350-63. PubMed ID: 12360496
    [No Abstract]   [Full Text] [Related]  

  • 29. The relationship between hepatocellular carcinoma and hepatitis B and C virus.
    Kohli A
    Clin Adv Hematol Oncol; 2016 Feb; 14(2):96-8. PubMed ID: 27057807
    [No Abstract]   [Full Text] [Related]  

  • 30. Relying on chimpanzees for hepatitis research.
    Rosania K
    Lab Anim (NY); 2013 Jun; 42(6):188. PubMed ID: 23689445
    [No Abstract]   [Full Text] [Related]  

  • 31. International society for antiviral research - 22nd international conference. Part 2.
    Walker K
    IDrugs; 2009 Jul; 12(7):411-2. PubMed ID: 19579157
    [No Abstract]   [Full Text] [Related]  

  • 32. [West nile virus. An unusual flavivirus with increased importance].
    Stock I
    Med Monatsschr Pharm; 2004 Apr; 27(4):112-20; quiz 121-2. PubMed ID: 15137587
    [No Abstract]   [Full Text] [Related]  

  • 33. The human liver-uPA-SCID mouse: a model for the evaluation of antiviral compounds against HBV and HCV.
    Meuleman P; Leroux-Roels G
    Antiviral Res; 2008 Dec; 80(3):231-8. PubMed ID: 18706933
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Resistance in viruses other than HIV.
    Griffiths PD
    Int J Infect Dis; 2002 Mar; 6 Suppl 1():S32-7. PubMed ID: 12044287
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Treatment predictors of a sustained virologic response in hepatitis B and C.
    Kau A; Vermehren J; Sarrazin C
    J Hepatol; 2008 Oct; 49(4):634-51. PubMed ID: 18715665
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Advances in the treatment of virus diseases.
    Rubenstein D; Tyrrell DA
    Practitioner; 1971 Oct; 207(240):510-5. PubMed ID: 4332181
    [No Abstract]   [Full Text] [Related]  

  • 37. Acyclic nucleoside phosphonates: past, present and future. Bridging chemistry to HIV, HBV, HCV, HPV, adeno-, herpes-, and poxvirus infections: the phosphonate bridge.
    De Clercq E
    Biochem Pharmacol; 2007 Apr; 73(7):911-22. PubMed ID: 17045247
    [TBL] [Abstract][Full Text] [Related]  

  • 38. The 17th International Conference on Antiviral Research.
    Buckheit RW
    Expert Opin Investig Drugs; 2004 Sep; 13(9):1207-12. PubMed ID: 15330752
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Antiviral Activity of Nordihydroguaiaretic Acid and Its Derivative Tetra-
    Merino-Ramos T; Jiménez de Oya N; Saiz JC; Martín-Acebes MA
    Antimicrob Agents Chemother; 2017 Aug; 61(8):. PubMed ID: 28507114
    [TBL] [Abstract][Full Text] [Related]  

  • 40. HEP DART 2003: Frontiers in drug development for viral hepatitis.
    Raney AK; Hamatake RK; Hong Z
    Expert Opin Investig Drugs; 2004 Mar; 13(3):289-93. PubMed ID: 15013947
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.